Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-010083
Filing Date
2021-05-13
Accepted
2021-05-13 07:11:42
Documents
73
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cerc-20210331.htm   iXBRL 10-Q 1172483
2 EX-10.1 kkclicenseagreement_redact.htm EX-10.1 602532
3 EX-31.1 q12021cercex-311.htm EX-31.1 11643
4 EX-31.2 q12021cercex-312.htm EX-31.2 11528
5 EX-32.1 q12021cercex-321.htm EX-32.1 10005
11 cerc-20210331_g1.jpg GRAPHIC 266582
  Complete submission text file 0001628280-21-010083.txt   8271296

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cerc-20210331.xsd EX-101.SCH 60896
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cerc-20210331_cal.xml EX-101.CAL 82334
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cerc-20210331_def.xml EX-101.DEF 376755
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cerc-20210331_lab.xml EX-101.LAB 715284
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cerc-20210331_pre.xml EX-101.PRE 494242
12 EXTRACTED XBRL INSTANCE DOCUMENT cerc-20210331_htm.xml XML 988010
Mailing Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850
Business Address 540 GAITHER ROAD SUITE 400 ROCKVILLE MD 20850 410-522-8707
Cerecor Inc. (Filer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37590 | Film No.: 21917163
SIC: 2834 Pharmaceutical Preparations